...
首页> 外文期刊>Coatings COMET(Companies Markets Economic Trends) >... Sud-Chemie is 'the right strategic fit' for Clariant
【24h】

... Sud-Chemie is 'the right strategic fit' for Clariant

机译:... Sud-Chemie是科莱恩的“正确战略选择”

获取原文
获取原文并翻译 | 示例
           

摘要

Clariant is planning to acquire most of the shares of rival German speciality chemical maker Sud-Chemie, and has signed agreements with its majority shareholders. An agreement has been reached with One Equity Partners, which owns 50.4% of Sud-Chemie and a number of family shareholders, which own approximately 46%. As a result, Clariant will acquire slightly above 95% of the outstanding shares. The shares of One Equity Partners are to be bought at a price of ?121 per Sud-Chemie share. The vast majority of the Sud-Chemie family shareholders will swap their shares into Clariant shares at a ratio of 1:8.84, says Clariant. The total value of the transaction is ?2.0 billion (CHF 2.5 billion). Hariolf Kottmann, Clariant's chief executive, says: "We are convinced that Sud-Chemie is the right strategic fit for Clariant. It complements our portfolio with high growth businesses, less cyclicality and it provides Clariant access to new attractive market segments. Sud-Chemie will further drive our profitable growth forward in the coming years."
机译:科莱恩计划收购竞争对手德国特种化学品制造商Sud-Chemie的大部分股份,并已与其大股东签署协议。与拥有50.4%的Sud-Chemie股权的One Equity Partners以及拥有约46%的许多家族股东已达成协议。结果,科莱恩将收购略高于95%的流通股。 One Equity Partners的股份将以每股Sud-Chemie股份121英镑的价格购买。科莱恩表示,Sud-Chemie家族的绝大多数股东将以1:8.84的比例将其股份换成科莱恩股份。交易总价值为20亿欧元(25亿瑞士法郎)。科莱恩首席执行官哈里奥夫·科特曼(Hariolf Kottmann)说:“我们坚信,南化学是科莱恩的正确战略选择。它以高增长的业务,较少的周期性补充了我们的产品组合,并为科莱恩提供了进入新的有吸引力的市场领域的机会。南化学在未来几年将进一步推动我们的盈利增长。”

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号